| pubmed-article:15897585 | rdf:type | pubmed:Citation | lld:pubmed |
| pubmed-article:15897585 | lifeskim:mentions | umls-concept:C0030705 | lld:lifeskim |
| pubmed-article:15897585 | lifeskim:mentions | umls-concept:C0677936 | lld:lifeskim |
| pubmed-article:15897585 | lifeskim:mentions | umls-concept:C0031327 | lld:lifeskim |
| pubmed-article:15897585 | lifeskim:mentions | umls-concept:C0442027 | lld:lifeskim |
| pubmed-article:15897585 | lifeskim:mentions | umls-concept:C0220825 | lld:lifeskim |
| pubmed-article:15897585 | lifeskim:mentions | umls-concept:C0205390 | lld:lifeskim |
| pubmed-article:15897585 | lifeskim:mentions | umls-concept:C0205210 | lld:lifeskim |
| pubmed-article:15897585 | lifeskim:mentions | umls-concept:C0964184 | lld:lifeskim |
| pubmed-article:15897585 | pubmed:issue | 10 | lld:pubmed |
| pubmed-article:15897585 | pubmed:dateCreated | 2005-5-17 | lld:pubmed |
| pubmed-article:15897585 | pubmed:abstractText | To determine the tolerability and pharmacokinetics of oral CI-1033, a pan-erbB tyrosine kinase inhibitor, administered over 14 consecutive days of a 21-day cycle. | lld:pubmed |
| pubmed-article:15897585 | pubmed:language | eng | lld:pubmed |
| pubmed-article:15897585 | pubmed:journal | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:15897585 | pubmed:citationSubset | IM | lld:pubmed |
| pubmed-article:15897585 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:15897585 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:15897585 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:15897585 | pubmed:status | MEDLINE | lld:pubmed |
| pubmed-article:15897585 | pubmed:month | May | lld:pubmed |
| pubmed-article:15897585 | pubmed:issn | 1078-0432 | lld:pubmed |
| pubmed-article:15897585 | pubmed:author | pubmed-author:ShinDong MDM | lld:pubmed |
| pubmed-article:15897585 | pubmed:author | pubmed-author:NemunaitisJoh... | lld:pubmed |
| pubmed-article:15897585 | pubmed:author | pubmed-author:SenzerNeilN | lld:pubmed |
| pubmed-article:15897585 | pubmed:author | pubmed-author:WilliamsAdrie... | lld:pubmed |
| pubmed-article:15897585 | pubmed:author | pubmed-author:ZinnerRalph... | lld:pubmed |
| pubmed-article:15897585 | pubmed:author | pubmed-author:CunninghamCas... | lld:pubmed |
| pubmed-article:15897585 | pubmed:author | pubmed-author:LenehanPeter... | lld:pubmed |
| pubmed-article:15897585 | pubmed:author | pubmed-author:BycottPaulP | lld:pubmed |
| pubmed-article:15897585 | pubmed:author | pubmed-author:SchlichtMicha... | lld:pubmed |
| pubmed-article:15897585 | pubmed:author | pubmed-author:EisemanIreneI | lld:pubmed |
| pubmed-article:15897585 | pubmed:author | pubmed-author:OlsonStephen... | lld:pubmed |
| pubmed-article:15897585 | pubmed:author | pubmed-author:ZentgraffRebe... | lld:pubmed |
| pubmed-article:15897585 | pubmed:issnType | Print | lld:pubmed |
| pubmed-article:15897585 | pubmed:day | 15 | lld:pubmed |
| pubmed-article:15897585 | pubmed:volume | 11 | lld:pubmed |
| pubmed-article:15897585 | pubmed:owner | NLM | lld:pubmed |
| pubmed-article:15897585 | pubmed:authorsComplete | Y | lld:pubmed |
| pubmed-article:15897585 | pubmed:pagination | 3846-53 | lld:pubmed |
| pubmed-article:15897585 | pubmed:dateRevised | 2009-11-19 | lld:pubmed |
| pubmed-article:15897585 | pubmed:meshHeading | pubmed-meshheading:15897585... | lld:pubmed |
| pubmed-article:15897585 | pubmed:meshHeading | pubmed-meshheading:15897585... | lld:pubmed |
| pubmed-article:15897585 | pubmed:meshHeading | pubmed-meshheading:15897585... | lld:pubmed |
| pubmed-article:15897585 | pubmed:meshHeading | pubmed-meshheading:15897585... | lld:pubmed |
| pubmed-article:15897585 | pubmed:meshHeading | pubmed-meshheading:15897585... | lld:pubmed |
| pubmed-article:15897585 | pubmed:meshHeading | pubmed-meshheading:15897585... | lld:pubmed |
| pubmed-article:15897585 | pubmed:meshHeading | pubmed-meshheading:15897585... | lld:pubmed |
| pubmed-article:15897585 | pubmed:meshHeading | pubmed-meshheading:15897585... | lld:pubmed |
| pubmed-article:15897585 | pubmed:meshHeading | pubmed-meshheading:15897585... | lld:pubmed |
| pubmed-article:15897585 | pubmed:meshHeading | pubmed-meshheading:15897585... | lld:pubmed |
| pubmed-article:15897585 | pubmed:meshHeading | pubmed-meshheading:15897585... | lld:pubmed |
| pubmed-article:15897585 | pubmed:meshHeading | pubmed-meshheading:15897585... | lld:pubmed |
| pubmed-article:15897585 | pubmed:meshHeading | pubmed-meshheading:15897585... | lld:pubmed |
| pubmed-article:15897585 | pubmed:meshHeading | pubmed-meshheading:15897585... | lld:pubmed |
| pubmed-article:15897585 | pubmed:meshHeading | pubmed-meshheading:15897585... | lld:pubmed |
| pubmed-article:15897585 | pubmed:year | 2005 | lld:pubmed |
| pubmed-article:15897585 | pubmed:articleTitle | Phase 1 clinical and pharmacokinetics evaluation of oral CI-1033 in patients with refractory cancer. | lld:pubmed |
| pubmed-article:15897585 | pubmed:affiliation | Mary Crowley Medical Research Center/Texas Oncology PA, Dallas, Texas, USA. jnemunaitis@mcmrc.com | lld:pubmed |
| pubmed-article:15897585 | pubmed:publicationType | Journal Article | lld:pubmed |
| pubmed-article:15897585 | pubmed:publicationType | Clinical Trial | lld:pubmed |
| pubmed-article:15897585 | pubmed:publicationType | Multicenter Study | lld:pubmed |
| pubmed-article:15897585 | pubmed:publicationType | Clinical Trial, Phase I | lld:pubmed |
| http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:15897585 | lld:pubmed |
